Literature DB >> 12869809

Dystonia update.

Maja Trost1.   

Abstract

PURPOSE OF REVIEW: Dystonia is a movement disorder with a complex and not fully understood pathophysiology. Its better understanding would enable more focused treatment for the disorder. In this review, we provide an overview of recent studies of the pathophysiology of primary and secondary dystonia, with an emphasis on functional brain imaging. Potential mechanisms underlying the beneficial effects of deep brain stimulation for dystonia are also summarized. RECENT
FINDINGS: The recognition of dysfunction at different levels of the nervous system has extended the classical notions of localized striatal abnormalities in primary dystonia. Recent biochemical studies have revealed evidence of abnormal torsion activity in DYT1 dystonia. Abnormal patterns of brain metabolism have also been identified using functional brain imaging in different dystonia genotypes. These findings, in conjunction with new electrophysiological techniques, can be utilized to help define a common mechanism for the neural dysfunction in dystonia.
SUMMARY: New insights into the pathophysiology of dystonia have been provided by recent studies using electrophysiology, biochemistry and human genetics, as well as functional brain imaging studies. These advances together may create the basis for new therapies for this disorder.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12869809     DOI: 10.1097/01.wco.0000084228.82329.4a

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  2 in total

1.  Microstructural white matter changes in primary torsion dystonia.

Authors:  Maren Carbon; Peter B Kingsley; Chengke Tang; Susan Bressman; David Eidelberg
Journal:  Mov Disord       Date:  2008-01-30       Impact factor: 10.338

2.  Neurodegeneration in an adolescent with Sjogren-Larsson syndrome: a decade-long follow-up case report.

Authors:  Kye Hee Cho; Sung Han Shim; Youngsoo Jung; Se Ra Sung; MinYoung Kim
Journal:  BMC Med Genet       Date:  2018-08-29       Impact factor: 2.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.